Respiratory News and Research

RSS

Infrared light allows characterization of pathogens

The bacterium Staphylococcus aureus (S. aureus) is commonly found in nature and frequently colonizes the skin and the upper respiratory tract of humans. A healthy immune system can fight the microorganism but once the immune system is weakened the pathogen can spread and lead to life-threatening diseases of the lungs, the heart and other organs.

15 Jul 2013

Three DACA-eligible students to participate in Summer Enrichment Program at SSOM

Loyola University Chicago Stritch School of Medicine has welcomed three Deferred Action for Childhood Arrivals eligible students into its Summer Enrichment Program.

15 Jul 2013

Comprehensive analysis of disease burden in US

In nearly every major cause of premature death - from ischemic heart disease to diabetes to interpersonal violence - the United States trails its economic peers, according to new research from a global collaborative of scientists led by the Institute for Health Metrics and Evaluation at the University of Washington.

12 Jul 2013

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive top-line results from its ongoing Phase I trial of ALN-TTRsc, a subcutaneously administered RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis.

12 Jul 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.

11 Jul 2013

WHO: People covered by anti-tobacco campaigns increased by almost 400 million

At 2.3 billion, the number of people worldwide covered by at least one life-saving measure to limit tobacco use has more than doubled in the last five years, according to the WHO Report on the Global Tobacco Epidemic 2013.

11 Jul 2013

Short-term exposure to air pollution increases risk of heart failure

Short-term exposure to most major air pollutants appears to increase the risk of being hospitalised for and dying from heart failure, according to a systematic review and meta-analysis of data from 12 countries published in The Lancet.

11 Jul 2013

IDSA and ASM collaborate to guide the best use of lab tests for diagnosis of infectious diseases

A new guide developed by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) will help physicians appropriately and accurately use laboratory tests for the diagnosis of infectious diseases. Laboratory test results drive approximately two-thirds of physicians' medical decisions.

11 Jul 2013

H7 influenza may spillover repeatedly into humans, say scientists

The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.

10 Jul 2013

McMaster University researchers identify three factors that influence pandemic influenza

Three waves of the deadliest influenza pandemic in history, known as the Spanish flu, hit England and Wales in 1918, just as World War 1 was coming to an end.

10 Jul 2013

Study reveals that contaminated ultrasound gel causes healthcare-associated infection

After a 2011 outbreak of P. aeruginosa, investigators at Beaumont Health System near Detroit, Michigan determined contaminated ultrasound gel was the source of bacteria causing the healthcare-associated infection.

10 Jul 2013

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced that the Therapeutic Goods Administration of Australia has approved KALYDECO (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene.

10 Jul 2013

Lifestyle modification programs may reduce risk of heart attack in people with coronary heart disease

Lifestyle modification programs that addressed at least two health behaviors lowered the risk of a fatal heart attack or stroke in people with coronary heart disease, finds a new systematic review in the American Journal of Preventive Medicine.

10 Jul 2013

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

The New Jersey Commission on Spinal Cord Injury Research awarded three grants to scientists at Kessler Foundation. The grants, which exceed $1.2 million, fund studies of assisted walking with Ekso, the impact of aging in the population with spinal cord injury (SCI) and the effects of electrical stimulation on bone loss.

10 Jul 2013

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013.

9 Jul 2013

Middle East respiratory syndrome coronavirus currently unlikely to cause a pandemic, finds study

New estimates of the transmissibility of the Middle East respiratory syndrome coronavirus (MERS-CoV) in humans suggest that it does not yet have pandemic potential, according to research published in The Lancet.

9 Jul 2013

Researcher receives $1.58M NIDCR grant to advance research on link between oral bacteria and fetal death

A new four-year, $1.58 million grant from the National Institute of Dental and Craniofacial Research, will allow a Case Western Reserve University School of Dental Medicine researcher to advance her work linking oral bacteria to fetal death.

9 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Immune response to TB bacterium varies between patients of different ethnic origin

The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.

5 Jul 2013

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

A group of Australian researchers, back in 2006, noted that there was a link between the severity of cystic fibrosis between sufferers who surfed, and sufferers who did not surf – and obviously Australia is a good place to spot that.

4 Jul 2013

Respiratory News and Research

Infrared light allows characterization of pathogens

Three DACA-eligible students to participate in Summer Enrichment Program at SSOM

Comprehensive analysis of disease burden in US

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

WHO: People covered by anti-tobacco campaigns increased by almost 400 million

Short-term exposure to air pollution increases risk of heart failure

IDSA and ASM collaborate to guide the best use of lab tests for diagnosis of infectious diseases

H7 influenza may spillover repeatedly into humans, say scientists

McMaster University researchers identify three factors that influence pandemic influenza

Study reveals that contaminated ultrasound gel causes healthcare-associated infection

TGA of Australia approves Vertex Pharmaceuticals' KALYDECO for cystic fibrosis

Lifestyle modification programs may reduce risk of heart attack in people with coronary heart disease

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Middle East respiratory syndrome coronavirus currently unlikely to cause a pandemic, finds study

Researcher receives $1.58M NIDCR grant to advance research on link between oral bacteria and fetal death

Soligenix announces personalized medicine collaboration with SciClone

Immune response to TB bacterium varies between patients of different ethnic origin

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News